Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Calcium carbonate/lansoprazole - Addpharma

Next Previous
X
Search
Drug Profile

Calcium carbonate/lansoprazole - Addpharma

Alternative Names: AD-212; AD-212-A

Latest Information Update: 16 Aug 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Addpharma
  • Class Anti-inflammatories; Antiulcers; Benzimidazoles; Ethers; Fluorinated hydrocarbons; Gastric antisecretories; Pyridines; Small molecules; Sulfoxides
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase I Gastro-oesophageal reflux

Most Recent Events

  • 19 Apr 2024 Addpharma completes a phase I trial in Gastro oesophageal reflux (In volunteers) in South Korea (PO, Tablet) (NCT06025773)
  • 15 Feb 2024 Phase-I development in Gastro oesophageal reflux is ongoing in South Korea
  • 28 Jan 2024 No recent reports of development identified for phase-I development in Gastritis in South Korea

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top